ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
Facile Single-Nanocomposite 4D Bioprinting of Dynamic Hydrogel Constructs with Thickness-Controlled Gradient.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Smart Bioinks for 4D Bioprinting: Requirements, Design, and Applications.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
- Discrete 2D Material Programming for 3D Shaping and Morphogenesis-Inspired 4D Bioprinting.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- 4D morphogenetic tissue engineering via gradient-crosslinked microporous hydrogel scaffolds.Materials today. Bio · 2026Article
- Approaching Scarless Wound Healing: From Passive Anti-Fibrotic to Proactive and Programmable Pro-Regenerative Strategies.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
- Advancing transdermal drug delivery through 4D bioprinting and dynamic skin modelling.Frontiers in drug delivery · 2026Review
- Facile Single-Nanocomposite 4D Bioprinting of Dynamic Hydrogel Constructs with Thickness-Controlled Gradient.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Article
- Engineering next-generation organoids: A review on bioprinting strategies, bioink innovations, and frontier applications.Journal of tissue engineeringReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The advent of 4D bioprinting has fueled significant progress in tissue engineering, but it faces major challenges such as limited options of smart bioinks and complexity of designing printing paths, limiting its broader application in tissue engineering. In this study, a smart composite hydrogel is first developed by combining gelatin, gelatin methacryloyl, and MXene (MX/GG), exhibiting excellent printability and shape-morphing capabilities. A facile and robust 4D printing strategy is proposed to fabricate MX/GG hydrogels with distinct spatial crosslinking gradients by simply tuning the domain-specific pattern thickness followed by a single UV exposure. Finite element analysis is applied to effectively guide the thickness-controlled shape-morphing process, resulting in precise alignment with the actual curved constructs and reliably predicting the shape transformation of CAD-designed patterns. Inspired by natural shape-morphing systems, a wide range of biomimetic constructs are successfully 4D printed, including unidirectional curved constructs (e.g., five-petal flower) and bidirectional curved constructs (e.g., scorpion). As a proof-of-concept, cell-laden MX/GG bioinks are 4D bioprinted into humidity-driven self-folding strips. Living cells experienced bending-associated strain within 3D constructs and proliferated and functioned effectively. Developed with the facile 4D printing strategy, the MXene-reinforced smart hydrogels hold significant promise for the biofabrication of diverse programmable dynamic tissues and organs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.